Spitzweg C - Search Results

1

A Novel Approach for Image-Guided ¹³¹I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.

Schug C, Gupta A, Urnauer S, Steiger K, Cheung PF, Neander C, Savvatakis K, Schmohl KA, Trajkovic-Arsic M, Schwenk N, Schwaiger M, Nelson PJ, Siveke JT, Spitzweg C. Schug C, et al. Among authors: spitzweg c. Mol Cancer Res. 2019 Jan;17(1):310-320. doi: 10.1158/1541-7786.MCR-18-0185. Epub 2018 Sep 17. Mol Cancer Res. 2019. PMID: 30224540 Free article.

2

Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.

Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. Spitzweg C, et al. Cancer Res. 2000 Nov 15;60(22):6526-30. Cancer Res. 2000. PMID: 11103823

3

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.

Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C. Scholz IV, et al. Among authors: spitzweg c. Gene Ther. 2005 Feb;12(3):272-80. doi: 10.1038/sj.gt.3302410. Gene Ther. 2005. PMID: 15510175

4

Cardiac reporter gene imaging using the human sodium/iodide symporter gene.

Miyagawa M, Beyer M, Wagner B, Anton M, Spitzweg C, Gansbacher B, Schwaiger M, Bengel FM. Miyagawa M, et al. Among authors: spitzweg c. Cardiovasc Res. 2005 Jan 1;65(1):195-202. doi: 10.1016/j.cardiores.2004.10.001. Cardiovasc Res. 2005. PMID: 15621047

5

A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.

Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C. Cengic N, et al. Among authors: spitzweg c. J Clin Endocrinol Metab. 2005 Aug;90(8):4457-64. doi: 10.1210/jc.2004-2140. Epub 2005 Jun 7. J Clin Endocrinol Metab. 2005. PMID: 15941870

6

Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.

Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC. Spitzweg C, et al. Hum Gene Ther. 2007 Oct;18(10):916-24. doi: 10.1089/hum.2007.081. Hum Gene Ther. 2007. PMID: 17931047

7

Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.

Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C. Willhauck MJ, et al. Among authors: spitzweg c. Gene Ther. 2008 Feb;15(3):214-23. doi: 10.1038/sj.gt.3303057. Epub 2007 Nov 8. Gene Ther. 2008. PMID: 17989705

8

The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.

Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Göke B, Morris JC, Spitzweg C. Willhauck MJ, et al. Among authors: spitzweg c. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1272-81. doi: 10.1007/s00259-008-0775-4. Epub 2008 Apr 11. Eur J Nucl Med Mol Imaging. 2008. PMID: 18404268

9

Gene therapy in thyroid cancer.

Spitzweg C. Spitzweg C. Horm Metab Res. 2009 Jun;41(6):500-9. doi: 10.1055/s-0029-1220744. Epub 2009 May 11. Horm Metab Res. 2009. PMID: 19434562 Review.

10

Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.

Klutz K, Russ V, Willhauck MJ, Wunderlich N, Zach C, Gildehaus FJ, Göke B, Wagner E, Ogris M, Spitzweg C. Klutz K, et al. Among authors: spitzweg c. Clin Cancer Res. 2009 Oct 1;15(19):6079-86. doi: 10.1158/1078-0432.CCR-09-0851. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters